Picloram Exposure Increases Early-Onset Colorectal Cancer Risk in Epigenetic Analysis

The Rising Tide of Early-Onset Colorectal Malignancy

The global incidence of early-onset colorectal cancer is rising at an alarming rate, yet the specific drivers behind this trend in patients under age 50 remain poorly understood [1]. While lifestyle factors contribute to risk, there is increasing focus on the exposome, which represents the cumulative measure of environmental influences and associated biological responses throughout a lifetime [1]. Exposure to environmental xenobiotics, including pesticides and industrial chemicals, can disrupt cellular homeostasis and trigger epigenetic modifications such as abnormal DNA methylation, a process where methyl groups are added to the DNA molecule to change gene activity without altering the underlying sequence [2]. These alterations are particularly concerning when they occur during critical developmental windows, as they may induce long-lasting changes that increase disease susceptibility later in life [2]. While some epigenetic changes are potentially reversible upon removal of the chemical trigger, identifying the specific culprits within a complex environment remains a significant clinical challenge [2, 3]. A recent study now offers fresh insights into how specific chemical exposures may be linked to the development of these early-onset malignancies.

Epigenetic Proxies for Environmental Exposure

To address the lack of direct environmental data in most cancer cohorts, the researchers constructed weighted methylation risk scores (MRS) to serve as proxies for exposome exposure. These methylation risk scores are statistical models that utilize DNA methylation patterns, which are chemical modifications to DNA that regulate gene expression without changing the genetic code, to estimate an individual's level of exposure to specific environmental factors. By analyzing these biological footprints, the study could quantify cumulative environmental influences that might otherwise be impossible to track through patient recall or standard medical records. This methodology allows clinicians to view the epigenome as a historical record of a patient's interaction with their environment, providing a more objective measure of long-term exposure than self-reported data. The analysis successfully confirmed several previously identified risk factors for colorectal cancer, including educational attainment, diet, and smoking habits, which served to validate the accuracy of the methylation risk score approach. Beyond these established factors, the researchers identified exposure to the herbicide picloram as a significant risk factor for early-onset colorectal cancer (Padj. = 0.00049). This association was further substantiated in a meta-analysis of six colorectal cancer cohorts (P = 0.021) that compared early-onset cases with patients diagnosed at age 70 or older. To provide real-world context, the authors employed population-based data from 81 U.S. counties spanning a 20-year period, which validated the link between picloram usage and increased cancer incidence (P = 2.87×10⁻³). These findings suggest that specific chemical exposures in the environment may be driving the rising rates of malignancy in younger populations.

Identifying Picloram as a Specific Risk Factor

The investigation into the environmental drivers of malignancy identified the herbicide picloram as a specific risk factor for early-onset colorectal cancer. While many environmental studies rely on subjective patient recall, this analysis utilized objective epigenetic markers to establish a clear link between chemical exposure and oncogenesis. The association between picloram exposure and the development of colorectal cancer in younger patients reached high statistical significance, yielding an adjusted p-value of 0.00049 (Padj. = 0.00049). This finding suggests that the herbicide, commonly used for broadleaf weed control in pastures and rangelands, may exert a biological influence that predisposes individuals to early malignant transformation in the colon and rectum. To ensure the robustness of these results, the researchers conducted a meta-analysis comprising six independent colorectal cancer cohorts, which confirmed the initial findings with a p-value of 0.021 (P = 0.021). A critical component of this analysis was the comparison between different age demographics to determine if the risk was uniform across all patients. The researchers specifically compared patients with early-onset colorectal cancer to patients diagnosed at age 70 or older, finding that the picloram association was distinct to the younger cohort. This age-stratified data emphasizes the specificity of the finding to the demographic under age 50, suggesting that the rising incidence of colorectal cancer in younger populations may be tied to specific environmental exposures that do not show the same correlation in late-onset cases.

Population-Level Validation and Clinical Implications

To move beyond individual epigenetic markers and assess the real-world impact of environmental toxins, the researchers utilized population-based data from 81 U.S. counties collected over a 20-year period for further validation. This large-scale epidemiological analysis confirmed the association between picloram usage and the incidence of early-onset colorectal cancer, yielding a p-value of 2.87×10⁻³ (P = 2.87×10⁻³). Such findings are particularly relevant as the incidence of colorectal cancer is rapidly rising in individuals younger than 50 years of age, a trend that is especially prevalent in high-income countries. This epidemiological shift closely parallels changes in the exposome, which is defined as the cumulative measure of environmental influences and the associated biological responses an individual experiences throughout their lifetime. Prior to this study, it had not been investigated whether these specific exposome factors are causally linked to the development of early-onset colorectal cancer, leaving a significant gap in the understanding of why younger, often low-risk patients are developing advanced malignancies. The study findings highlight the critical role of the exposome in the risk profile of early-onset colorectal cancer, suggesting that traditional risk assessments focusing solely on genetics and lifestyle may be incomplete. By establishing a link between a specific herbicide and cancer incidence through both molecular and population-level data, the results underscore an urgent need for targeted personal and policy-level interventions to address environmental risk factors. For the practicing clinician, these data suggest that environmental history may become an increasingly important component of patient screening. As the medical community seeks to address the rising burden of colorectal cancer in younger populations, these findings provide a biological basis for advocating for stricter environmental regulations and more personalized risk stratification based on cumulative chemical exposures.

References

1. Maas SC, Baraibar I, Lemler L, et al. Abstract PR003: Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores. Clinical Cancer Research. 2025. doi:10.1158/1557-3265.earlyonsetca25-pr003

2. Sobral AF, Cunha A, Costa I, Silva‐Carvalho M, Silva R, Barbosa DJ. Environmental Xenobiotics and Epigenetic Modifications: Implications for Human Health and Disease. Journal of Xenobiotics. 2025. doi:10.3390/jox15040118

3. Anviksha A, Reddy MS. Comprehensive Biotechnological Strategies for Podophyllotoxin Production from Plant and Microbial Sources. Planta Medica. 2024. doi:10.1055/a-2504-3069